← ANALYST RATINGS · TIPRANKS
Fate Therapeutics (FATE): analyst forecast and price target
Analyst consensus
Moderate Buy1 Buy2 Hold0 Sell
Ratings of 3 analysts in the last 3 months · top analysts only12-month forecast
Based on 3 price targets given in the last 3 months, the average target is $8.00, the highest $8.00, the lowest $8.00. The average is +346.9% from the last price of $1.79.
Analyst ratings 10
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $2.00 → $1.50−25.0% | Hold | −16.2% | Reiterated | 17.10.26on TipRanks 04:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $2.50 → $2.00−20.0% | Hold | +11.7% | Reiterated | 09.10.26on TipRanks 07:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $2.50 → $2.00−20.0% | Hold | +11.7% | Reiterated | 09.10.26on TipRanks 07:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $2.50 → $2.00−20.0% | Hold | +11.7% | Reiterated | 09.10.26on TipRanks 07:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $2.50 → $2.00−20.0% | Hold | +11.7% | Reiterated | 09.10.26on TipRanks 07:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $2.50 → $2.00−20.0% | Hold | +11.7% | Reiterated | 09.10.26on TipRanks 07:05 | — | |
| Gil Blum★★★★★★★★★★#949 · hits 43% · avg +12.5% | Needham | — | Hold | — | Reiterated | 05.10.26on TipRanks 06:55 | +4.1%next day −6.3% · 5 days −12.8% | ↗ |
| Unknown Analyst | Mizuho Securities | $8.00 | Buy | +346.9% | Reiterated | 17.08.26on TipRanks Aug 18 00:05 | +2.4%next day −1.6% · 5 days −5.7% | ↗ |
| Unknown Analyst | Wedbush | $7.00 | Buy | +291.1% | Reiterated | 14.08.26on TipRanks Aug 17 05:55 | +2.2%next day +2.4% · 5 days −8.0% | ↗ |
| Edward Tenthoff★★★★★★★★★★#3650 · hits 41% · avg +3.5% | Piper Sandler | $6.00 → $8.00+33.3% | Buy | +346.9% | Reiterated | 14.08.26on TipRanks 08:20 | +2.2%next day +2.4% · 5 days −8.0% | ↗ |
| Unknown Analyst | Wells Fargo | $2.50 → $3.50+40.0% | Hold | +95.5% | Assigned | 14.08.26on TipRanks 08:20 | +2.2%next day +2.4% · 5 days −8.0% | ↗ |
| Tara Bancroft★★★★★★★★★★#361 · hits 55% · avg +30.3% | TD Cowen | — | Hold | — | Reiterated | 13.08.26on TipRanks Aug 17 05:55 | −8.0%next day +2.2% · 5 days −0.8% | ↗ |
| Robert Burns★★★★★★★★★★#272 · hits 52% · avg +25.9% | H.C. Wainwright | $7.00 | Buy | +291.1% | Reiterated | 09.07.26on TipRanks 11:26 | +5.3%next day −0.8% · 5 days −12.1% | ↗ |
| Tazeen Ahmad★★★★★★★★★★#1537 · hits 60% · avg +5.8% | Bank of America Securities | $2.00 → $2.20+10.0% | Hold | +22.9% | Reiterated | 21.05.26on TipRanks May 22 05:10 | +13.9%next day +6.8% · 5 days +33.4% | ↗ |
| Roger Song★★★★★★★★★★#4779 · hits 41% · avg +2.6% | Jefferies | $4.00 | Buy | +123.5% | Initiated | 19.05.26on TipRanks 15:20 | +9.9%next day −3.7% · 5 days +23.1% | ↗ |
| Peter Lawson★★★★★★★★★★#602 · hits 47% · avg +15.5% | Barclays | $2.00 | Buy | +11.7% | Reiterated | 28.10.25on TipRanks 03:15 | −4.1%next day −10.1% · 5 days −18.4% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Fate Therapeutics
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 05.10.26: target $6.70 at a price of $2.32 (+188.8%); now: $6.62 at $1.79 (+270.1%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 8 | 9 | 6 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 3 | 4 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 29.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.27 (from $-0.31 to $-0.24). Last quarter: $-0.25.
Sales
Next quarter’s sales estimate — $1M (from $0M to $2M). Last quarter: $2M.
Best top-analyst consensus in the sector · Healthcare
About Fate Therapeutics
- CEO: Bahram Valamehr
- Employees: 161
- 12278 Scripps Summit Drive, San Diego, CA, 92131, US
- www.fatetherapeutics.com
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating advanced, programmed cellular immunotherapies. These innovative treatments are designed to combat cancer and various immune disorders across the globe. A significant portion of its development pipeline concentrates on NK- and T-cell immuno-oncology programs. Key candidates include FT516, which targets acute myeloid leukemia (AML), B-cell lymphoma, and advanced solid tumors; FT596 for B-cell lymphoma and chronic lymphocytic leukemia; FT538, addressing AML and multiple myeloma; FT576, also focused on multiple myeloma; FT819, aimed at both hematologic malignancies and solid tumors; FT536, another program for solid tumors; and FT500, intended for advanced solid tumors. The company also actively engages in strategic collaborations to advance its research and development. It holds an agreement with Ono Pharmaceutical Co. Ltd. for the joint development and commercialization of two novel, "off-the-shelf" iPSC-derived CAR T-cell therapies. Furthermore, Fate Therapeutics maintains a research collaboration and licensing deal with Juno Therapeutics, Inc., focusing on identifying small molecule modulators that can enhance the therapeutic efficacy of genetically engineered T-cell immunotherapies. A separate collaboration and option agreement exists with Janssen Biotech, Inc. Established in 2007, Fate Therapeutics, Inc. is based in San Diego, California.
Data from the stock’s TipRanks forecast page, read 156 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗